Modern Chinese Medicine Group Co. Ltd. (HK:1643) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Modern Chinese Medicine Group Co., Ltd. is set to unwind its contractual arrangements and increase its direct ownership in the Chinese market, following the lifting of restrictions on foreign investments in traditional Chinese medicine. This strategic move aligns with the recent changes in the 2024 Catalogue by the National Development and Reform Commission, allowing greater foreign participation in the manufacturing sector. The company anticipates completing the necessary reporting by the second half of 2026.
For further insights into HK:1643 stock, check out TipRanks’ Stock Analysis page.